Clarus Closes $910M Life Science Investment Fund

Clarus, a Cambridge, MA- and South San Francisco, Calif.-based life science investment firm, closed its fourth fund, at $910m.

Clarus IV, L.P., the fourth investment fund formed and managed by Clarus, brings its total assets under management to more than $2.6 billion.

Led by Managing Directors Emmett Cunningham, Nicholas Galakatos, Robert Liptak, Scott Requadt, Nicholas Simon and Kurt Wheeler, Clarus is a global investment firm dedicated to life sciences. The firm manages over $2.6 billion, and has invested in more than 50 private and public companies in the biotechnology, medical device and diagnostic spaces.
Clarus’ team includes Chief Scientific Advisor Dennis Henner, Partners Michele Park and Barry Gertz, Principal Ari Brettman, Associate Lazar Dimitrov, Senior Advisor Edward Scolnick and Venture Partners Bob DeBenedetto, Kiran Reddy and William Young.



Join the discussion